PQR-530

CAS No. 1927857-61-1

PQR-530 ( PQR530 )

Catalog No. M13022 CAS No. 1927857-61-1

PQR-530 (PQR530) is a potent, BBB penetrant, dual pan-PI3K/mTOR inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 102 Get Quote
10MG 147 Get Quote
25MG 295 Get Quote
50MG 439 Get Quote
100MG 642 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    PQR-530
  • Note
    Research use only, not for human use.
  • Brief Description
    PQR-530 (PQR530) is a potent, BBB penetrant, dual pan-PI3K/mTOR inhibitor.
  • Description
    PQR-530 (PQR530) is a potent, BBB penetrant, dual pan-PI3K/mTOR inhibitor with Kd of 0.3/1/6/11/10 nM for mTOR/PIK3CA/PIK3CB/PIK3CD/PIK3CG, respectively; effectively cross the blood-brain barrier and increase seizure threshold in a mouse model of chronic epilepsy.
  • Synonyms
    PQR530
  • Pathway
    PI3K/Akt/mTOR signaling
  • Target
    PI3K
  • Recptor
    PI3K
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    1927857-61-1
  • Formula Weight
    407.42
  • Molecular Formula
    C18H23F2N7O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    NC1=NC=C(C2=NC(N3[C@@H](C)COCC3)=NC(N4CCOCC4)=N2)C(C(F)F)=C1
  • Chemical Name
    (S)-4-(difluoromethyl)-5-(4-(3-methylmorpholino)-6-morpholino-1,3,5-triazin-2-yl)pyridin-2-amine

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Brandt C, et al. Neuropharmacology. 2018 Aug 3;140:107-120.
molnova catalog
related products
  • Autophinib

    Autophinib is a novel, potent autophagy inhibitor that inhibits autophagy induced by starvation (IC50=90 nM) or rapamycin (IC50=40 nM) by targeting the lipid kinase VPS34 (IC50=19 nM).

  • AZD8835

    AZD8835 (AZD-8835) is a potent, selective inhibitor of PI3Kα and PI3Kδ with IC50 of 6.2 and 5.7 nM.

  • Gedatolisib

    A highly potent, selective, dual PI3K/mTOR inhibitor.